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1. Introduction
  Respiratory tract infection is a leading cause of morbidity 
and mortality in children; however, the actual global burden 
of diseases attributable to influenza virus in children is 
unknown[1]. 
  Nevertheless, influenza A viral infection propensity is 
attributed to frequent antigenic shifts and drifts as well 
as possessing a capacity to cause annual epidemics and 
occasional pandemics[2]. Prompt and appropriate diagnosis 
and therapy affect individual patients as well as whole 
society, because local outbreaks may be detected and 
control measures can be initiated[3]. 
  Moreover, it is difficult to diagnose influenza clinically, 
because its symptoms are nonspecific and a variety of 
diseases share similar symptoms. A symptom complex for 
influenza-like illness (ILI) has been used as a predictive 
tool for the diagnosis of influenza infection at the primary-
care level[4]. Thus, recent appearance and worldwide 
spread of novel influenza A virus have highlighted the need 
to commercially available, widely used rapid influenza 
diagnostic tests (RIDTs) for their ability to detect these viral 
antigens in respiratory clinical specimens[5].
  Although on 10 August, 2010, the Director General of the 
World Health Organization (WHO) has announced that the 
world is no longer in phase 6 of influenza pandemic alert 
and we are now moving into the post-pandemic period, 
the virus transmission is still highly active in many parts[6]. 
However, the situation in Egypt was not yet clear. Thus, the 
objective of this study—during the post-pandemic period 
of swine flu—was to provide information regarding the 
actual burden of influenza A viral infections in Egyptian 
children. 
Objective: To screen children with influenza like illness or with symptoms of acute respiratory 
tract infections for influenza A virus infection—post swine flu pandemic era—using rapid 
influenza diagnostic tests. Methods: During two years (2010 & 2011), 1 200 children with influenza 
like illness or acute respiratory tract infections (according to World Health Organization criteria) 
were recruited. Their ages ranged from 2-60 months. Nasopharyngeal aspirates specimens were 
collected from all children for rapid influenza A diagnostic test. Results: Influenza A virus 
rapid test was positive in 47.5% of the children; the majority (89.6%) were presented with lower 
respiratory tract infections. Respiratory rate and temperature were significantly higher among 
positive rapid influenza test patients. Conclusions: Influenza A virus infection is still a major 
cause of respiratory tract infections in Egyptian children. It should be considered in all cases with 
cough and febrile episodes and influenza like symptoms even post swine flu pandemic.
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2. Subjects and methods
2.1. Study design
  This cross sectional pilot observational study was 
performed in two Egyptian governorates, Gharbbia (North) 
and Fayoum (South), during two years 2010 & 2011 (post 
swine-flu H1N1 pandemic). One thousand and two hundreds 
children (760 males & 460 females) with either ILI or with 
symptoms of acute respiratory tract infections defined by 
WHO[6] were recruited from primary health centers. Their 
ages ranged from 2-60 months. Distribution according to 
residence showed that 920 children were rural inhabitants, 
while 280 were urban.
  An informed consent was obtained from the parents of 
children who provided specimens. The study protocol was 
approved by the Research Ethics Committee of Ain Shams 
University. Nasopharyngeal aspirates specimens were collected 
and transported immediately to the laboratory for RIDT. 
2.2. Definition of influenza virus infection
  ILI was defined according to the criteria proposed by WHO: the 
presence of fever plus at least one upper-respiratory symptom 
(cough, sore throat, or rhinorrhea) and one constitutional 
symptom (headache, malaise, or myalgia)[6]. Children with ILI 
were considered to have influenza A infection if the RIDT 
was positive. 
2.3. Clinical severity score of acute respiratory tract infection
  Based on variables reported in previous studies[10,11], a 
severity index was defined by assigning 1 point to each 
of the following: use of supplemental oxygen, duration of 
hospital stay 曒5 days, and admission to an intensive care 
unit.
2.4. Data collection
  Demographic data, underlying medical conditions known 
to be risk factors for influenza-related complications (e.g., 
cardiac diseases, bronchial asthma, diabetes mellitus, and 
obesity)[13], clinical features at presentation, laboratory 
test results, radiographic findings, influenza-related 
complications, and treatment course of each patient were 
collected from their medical records.
2.5. Rapid influenza test
  Nasopharyngeal swabs from children were tested by 
QuickVue Influenza A rapid influenza antigen test (Quidel 
Corp., San Diego, CA, USA), according to the manufacturer’s 
instructions and as mentioned in previous study[12]. This test 
provides rapid visual qualitative immunochromatographic 
assay for influenza type A nucleoprotein antigen extracted 
from the nasal swab specimen by double antibody sandwich 
method. Patients were considered to have influenza A virus 
when the test was positive.
2.6. Statistics
  Statistical analyses were performed using the SPSS software 
v.15 (SPSS, Inc., Chicago, IL, USA). Student’s t-test was used 
to compare continuous variables and Fisher’s exact test was 
used to compare dichotomous variables. Moreover, variables 
that were significant in univariate analyses were entered 
into a multivariate analysis using a logistic regression model 
to identify independent factors associated positively with 
influenza virus infection. Two-tailed P values <0.05 were 
considered to indicate statistical significance.
  Receiver operating characteristic curves were plotted for 
single symptoms and various symptom combinations. The 
diagnostic accuracy of single and combined symptoms was 
assessed by calculating area under the receiver operating 
characteristic curves. Assessment of positive predictive 
value (PPV), negative predictive value (NPV), specificity, 
and sensitivity were done to identify best predictors of an 
influenza infection. PPVs were compared for individual 
symptoms, as well as combinations of symptoms.
  PPV indicates positive predictive value, the probability of 
having laboratory-confirmed influenza when the symptom 
is present; NPV, negative predictive value, the probability 
of not having laboratory-confirmed influenza when the 
symptom is not present; sensitivity, the probability of having 
the symptom when the patient has laboratory-confirmed 
influenza; and specificity, the probability of not having 
the symptom when the patient does not have laboratory-
confirmed influenza (i.e., when the test result for influenza is 
negative).
3. Results 
  Children’s demographic and clinical data are presented in 
Table 1. RIDTs for influenza A virus (H1N1) infection were 
positive in 47.5% (570/1 200). The most frequent symptoms 
were fever and respiratory symptoms (Table 2), while 
gastrointestinal symptoms, including nausea/vomiting, 
diarrhea, and abdominal pain, were observed in 36.8% of 
these pediatric patients.
  Most (83%) children were less than 5 years of age with 
mean age of (24.76±16.27) months. The mean age of children 
with influenza A virus (H1N1) infection was greater than 
that of children with non-influenza illnesses (P<0.05). 
From total recruited children, 61.7% were males (male sex 
predominates) and also majority of children were recruited 
from rural areas (76.7%).
  Most of the positive cases (510/570; 89.6%) were diagnosed 
to have lower respiratory tract infections, while 10.4% had 
only upper respiratory tract infections with ILI. Those with 
lower respiratory tract infections were admitted to the 
hospital. The mean length of hospital stay was 4.3 days. 
Eighty one children with lower respiratory tract infections 
(81/510; 15.68%) had influenza-associated complications in 
the form of secondary bacterial pneumonia. Ten children 
required admission to the intensive care unit. Two hundreds 
children had leukocyte counts <5 000/毺L and only fifty 
had leukocyte counts >15 000/毺L. Children with positive 
influenza A virus (H1N1) infection were more likely to have 
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leucopenia when compared to children with non-influenza 
illness (P<0.05). 
  According to the guidelines[6],  oseltamivir was 
recommended to be prescribed to children at the age of 
5 years old or less who had ILI and also had a positive 
RIDT result, complicated influenza or at-risk conditions 
for complications as defined by the WHO. Thus, antiviral 
therapy with oseltamivir was administered to 842/1 200 (70%) 
children, the youngest of whom was 15 month of age. Three 
hundreds and eighty five children with ILI (31.6%) have 
received parenteral or oral antibacterial therapy.
Table 1
Demographic and clinical data of studied children.  
Item
Patients according to rapid test
P value
Positive (n=570) Negative (n=630)
Age (Months) 26.76±6.276 18.40±7.672  0.001*
Male:Female 400:170 340:290 0.553
Rural:Urban 430:140 490:140 0.605
Duration of symptoms 
(days)
  3.02±1.334  2.87±1.563 0.557
Weight % for age and 
sexa
49.70±31.28 53.70±21.134 0.513
Height % for age and 
sexa
  41.58±27.378 48.72±28.759 0.070
Passive smokers 451/570 (78.9%) 129/630 (20.6%)  0.001
*
Respiratory rate
(breaths per minute)
40.45±7.229 35.52±5.603  0.013*
Clinical severity score 3±1 0±1  0.001*
Hospital admissions 510/570 (89.6%) 200/630 (31.7%)  0.001
*
Length of hospital stay 
(days)
4.3±2.6 2.0±1.5  0.046*
Age, duration of symptoms, weight % for age and sex, height % for age 
and sex, respiratory rate, clinical severity score, and length of hospital 
stay are expressed as mean±SD. *Statistically significant. aWeight & 
Height are expressed as "Percentile" for the same age and sex (Those 
are done for standardization of growing children of different ages and 
sex).
  Univariate regression analysis (Table 2) showed that 
children with positive influenza A virus (H1N1) infection 
were more likely to have fever (P=0.048), cough (P=0.001), 
headache (P=0.001), malaise (P=0.001), myalgia (P=0.001), 
and sore throat (P=0.001), compared with those who did not 
have influenza. 
Table 2
Univariate predictive analysis of influenza-like illness (ILI) symptoms 
for influenza A infection in the Egyptian children. 
Symptom Manifestation
Patients according to 
rapid test (%)
P value
Positive 
(n=570)
Negative  
(n=630)
Fever      100.0 92.1  0.048*
Respiratory 
symptoms
Cough 94.7 82.5  0.001*
Coryza 71.9 63.4 0.203
Sore throat 57.9 19.0  0.001*
Any 98.2 87.3 0.002
Constitutional 
symptoms
Headache 47.3 15.8  0.001*
Malaise 22.8   6.3  0.001*
Myalgia 57.9 19.0  0.001*
Any 77.2 31.7  0.001*
Gastrointestinal 
symptoms
Nausea/vomiting 22.8 28.6 0.334
Abdominal pain 12.3 14.3 0.811
Diarrhea 35.1 44.4 0.074
Any 36.8 46.0 0.121
*Statistically significant.
  Multivariate regression analysis showed that sore throat and 
fever significantly increased the odds of having influenza A 
virus infection by more than 3-fold predictivity index (OR= 
3.9; 95% CI: 1.92-7.35) and 7-fold predictivity index (OR= 
7.5; 95% CI: 4.01-14.32), respectively. 
  We further evaluated the performance of individual symptoms 
and symptom combinations as well as the rapid diagnostic test 
for the diagnosis of influenza infection (Table 3). Predictive 
Table 3
Sensitivity and specificity of predictive symptoms among influenza A virus infected children. 
Symptom Manifestation PPV NPV Sensitivity (%) Specificity (%)
Single symptom Fever 77.84 47.12 76.0 60.0
Cough 69.41 60.90 94.0 21.3
Coryza 76.58 49.24 72.0 34.2
Sore throat 85.43 40.33 58.0 82.4
Any respiratory symptom 71.14 69.89 88.2 13.1
Headache 83.40 41.13 43.7 86.0
Malaise 62.87 71.46 22.8 95.0
Myalgia 86.43 79.86 58.9 79.0
Any constitutional symptom 78.94 67.12 77.7 67.0
Combined symptoms Fever+cough 72.41 53.32 67.0 64.0
Fever+any respiratory symptom 81.45 48.21 66.7 72.3
Fever+cough+any constitutional 79.02 46.81 65.5 68.4
Any ILI 79.96 40.02 76.8 77.4
PPV indicates positive predictive value, the probability of having laboratory-confirmed influenza when the symptom is present; NPV, negative 
predictive value, the probability of not having laboratory-confirmed influenza when the symptom is not present; sensitivity, the probability of 
having the symptom when the patient has laboratory-confirmed influenza; and specificity, the probability of not having the symptom when the 
patient does not have laboratory-confirmed influenza (i.e., when the test result for influenza is negative).
Adel Khattab et al./Asian Pacific Journal of Tropical Medicine (2013)693-698696
symptoms showed a sensitivity of 76.8% and a specificity of 
77.4% in identifying influenza A virus infection from non-
influenza illness. 
  Moreover, another particular interest was the PPV 
proportion of those with a symptom who were confirmed 
positive for influenza as shown in Table 3. The PPV for 
baseline fever and cough was 72.41%, with sensitivity and 
specificity values of 67.0% and 64.0%, respectively. The PPV 
for baseline cough and fever was even higher (PPV=84.6%) 
in children with time from onset of 36 to 48 hours. However, 
combining other symptoms did not increase the PPV 
substantially. However, as illustrated in Figure 1, the 
probability of a child having confirmed influenza increased 
with increasing baseline temperature and it was higher 
in patients with cough than in those without cough. The 
proportion of children who were confirmed to be positive for 
influenza RIDT exceeded 80% when baseline temperature 
was above 38 曟.
100
90
80
70
60
50
40
30
20
10
0
P
er
ce
nt
ag
e 
of
 c
hi
ld
re
n 
po
si
ti
ve
 fo
r 
R
ID
T
 (%
)
Patients with cough
Patients without cough
36                    37                    38                   39                    40                   41 
Baseline temperature (曟)
Figure 1. Frequency of positive rapid influenza A diagnostic test 
(RIDT) in patients in relation to fever and cough
4. Discussion
  Influenza is a major health threat throughout the world, 
yet many countries lack even rudimentary influenza 
surveillance systems. Furthermore, influenza surveillance 
in developing countries often includes only major cities due 
to limited laboratory resources in outlying areas and poor 
infrastructure, e.g., lack of electrical power. Consequently, 
data are lacking about the types of influenza viruses that are 
circulating and the burden of influenza-related disease in 
the developing world[8].
  Though reverse transcriptase-polymerase chain reaction 
and viral isolation are the preferred diagnostic methods, 
rapid influenza tests are valuable for their ease of use and 
laboratory-independence[12,14]. The precise origins for acute 
respiratory illnesses are rarely identified[15,16]. Hence, in 
most respiratory viral diseases, establishment of the specific 
viral cause is neither necessary (i.e., does not direct therapy) 
and thus is not cost-effective. However, it is different for 
influenza virus infection, for which specific antiviral therapy 
has been available for many years. The introduction of 
the new neuraminidase inhibitors has made the need for 
influenza diagnosis a challenge[16,17].
  This work was designed to screen the incidence of 
influenza A virus infection in Egyptian children with ILI in 
two consecutive post winter seasons (post swine-origin H1N1 
pandemic) in Gharbbia and Fayoum governorates using one 
step influenza A rapid test. Among 1 200 children with ILI 
and/or symptoms of acute respiratory tract infection, 47.5% 
were positive in RIDT for influenza A infections.
  Parallel to our research, the latest unpublished Egyptian 
Influenza report 2012 by the Egyptian Ministry of Health 
(EMOH) reported that mean age for documented children 
cases of H1N1 infections in Egypt from June 2009 to the 
end of 2011 was 8.2 years with standard deviation 4.5
(13 782 cases) with case fatality rate 0.5% (71 deaths). Primary 
school age group (6-12 years) showed the highest case 
fatality rate (39.8%, 27 deaths), followed by pre-school age 
group (32.5%, 25 deaths), and the last was 12-18 year age 
group (27.6%, 19 deaths). Distribution of Egyptian children 
with mortality related to H1N1 infection showed that 56.3% 
of cases were males and 68.7% were from urban area. Most 
of cases were 67.9% during the year 2009 (46 deaths), then 
26.1% (20 deaths) during 2010 and just 6% (5 deaths) during 
2011.
  However, our study concentrated upon the pre-school 
age children, which seems to be the 2nd most affected 
age group in Egypt (according to the EMOH report). Our 
results still show that influenza A virus group was still 
highly disseminated (around half of ILI affected children 
were positive). Nevertheless, H1N1 virus was not tested 
in particular, but this may point to its persistent high 
prevalence. On the other hand, documented reduction of 
children deaths due to H1N1 may be explained by developed 
immunity to the virus year after year. This may explain 
the result in our study that 10 children were admitted to 
intensive care unit, but none of the study children died.
  Similarly, high prevalence of male sex affection in our 
study is parallel to that in the EMOH’s documents. However, 
most of the documented H1N1 deaths in Egypt were from 
urban cities and towns. Our study spot lighted that more 
rural children were presented with ILI. This discrepancy 
could be explained by better diagnostic reports related to 
urban childhood deaths. Our study may point out that even 
rural deaths due to influenza related infections may be much 
more than urban deaths but better attention for diagnosis 
and reporting.
  However, human influenza incidence peaks in the 
Northern and Southern Hemispheres during their respective 
winters[18], yet despite recognition of this phenomenon 
for at least a hundred years[19]. The mechanisms driving 
influenza seasonality are not well understood[20-22]. Several 
competing hypotheses have been proffered, including 
biological, sociological and environmental explanations, but 
none have been definitively established[22]. The pattern of 
influenza seasonality in humans appears different in tropical 
and subtropical areas, with high year-round circulation 
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and semi-annual peaks in incidence[23-25]. However, in the 
tropics, understanding the seasonal pattern of influenza in 
humans is further hampered by a lack of routinely collected 
incidence data[26].
  For that, in our study, Egyptian children with ILI were 
recruited all through the year even in spring and summer 
with relative disappearance of the well evident peak of 
incidence in autumn and winter. This also shows a novel 
pattern of influenza seasonality in Egypt.
  In agreement with the objects included by Ji et al[27], most 
children in our study were less than 5 years of age with mean 
age of (24.76±16.27) months. Nevertheless, the mean age of 
children with influenza A virus infection was greater than 
that of children with non-influenza illnesses. In contrast 
to Zaraket et al who screened influenza virus infections 
in Lebanese children with influenza like symptoms, the 
average age of their studied children was (5.5±4.6) years 
old[28]. This difference may be due to screening in winter 
and school season.
  Smoking is believed to exacerbate respiratory diseases 
by harming respiratory defense mechanisms[29]. Young 
children in day care or those exposed to tobacco smoke 
can have as many as 10 episodes of infections over 1 year, 
even with a healthy immune system[30]. Moreover, children 
of smokers had more childhood respiratory infections 
and hospitalizations for respiratory illness compared 
with children of nonsmokers also; passive smoking for 
two cigarettes increased the likelihood of experiencing 
respiratory symptoms[30]. The present study reported that 
451/570 (78.9%) among positive influenza A infections were 
passive smokers. In contrast to van Gageldonk-Lafeber 
et al who studied the environmental risk factors for acute 
respiratory tract infections in Netherlands, they reported 
only 35% were passive smokers[31]. 
  This work aimed also to determine if there are certain 
clinical symptoms and signs that might help clinician 
to discriminate influenza infection from illness due to 
other respiratory viruses. The most common presenting 
symptoms among individuals with influenza A positive were 
cough, myalgia, and weakness, consistent with previous 
studies[32,33]. 
  In this population, the PPV of cough and fever was 72.41%, 
with 67.0% sensitivity and 64.0% specificity. The PPV rose 
even further as the height or degree of fever at recruitment 
increased. Thus, during periods when influenza virus is 
circulating within a community, a high index of suspicion is 
warranted in patients who are seen with acute onset of cough 
and fever (body temperature 曒37.8 曟)[32]. This also agrees 
with Ohmit et al. who reported that, despite the absence of 
one commonly accepted definition for high-probability ILI, 
using a definition of fever >38.2 曟 with cough, it had a high 
positive predictive value (83%) for laboratory-confirmed 
influenza[33]. However, the selection of children with defined 
symptoms of ILI like fever may have overestimated PPV that 
would actually be observed among practicing physicians in 
the community. 
  The sensitivity and predictive values of ILI criteria for the 
diagnosis of influenza have varied among studies, with PPV 
ranging from 23% to 81%[32,33]. Our study reported that “ILI” 
symptoms PPV of influenza A infections was 79.96% with a 
sensitivity of 76.8%.
  The burden of laboratory confirmed influenza infection 
in our study population of individuals with defined ILI was 
47.5%. Also, Arifeen et al showed that 58% of the studied 
children had influenza A in a population-based surveillance 
for influenza virus among children under 5 years of age 
with acute infectious respiratory illness between April 2004 
and November 2005[34]. That is to say, influenza A family 
of viruses seems to be accused for about half of the ILI 
in children at different populations and within different 
circumstances of place and time.
  Moreover, these findings come in consistent with reported 
seasonality of influenza infection from the population based 
surveillance in Bangladesh, where the peak season was April 
to September. This seasonality is in contrast to temperate 
zones, where peak transmission occurs between September 
and March[35].
  Little is known about the seasonality of influenza viruses 
in tropical and sub-tropical countries, where temperature 
fluctuations are generally less extreme than in temperate 
regions. Longitudinal studies in Nicaragua[24] and Hong 
Kong[23] have demonstrated the importance of influenza 
year-round as a cause of respiratory infections in children, 
but there is an evidence that seasonal peaks in incidence of 
human influenza do occur and appear to vary in number and 
timing between countries and from year to year. 
  In Egypt, all meteorological variables (temperature, 
precipitation, relative humidity and absolute humidity, 
measured as vapor pressure) exhibited statistically 
significant seasonal patterns with period length 1.18 
years/cycle or 14 months/cycle[26], which may explain 
unseasonality and respectable burden of influenza A and its 
circulation in whole year-round.
  In conclusion, although swine flu influenza pandemic is 
over, evidence of predominate influenza A virus infection 
in Egyptian children is still present. Developed immunity to 
the newly developed virus has reduced the ugly face of the 
infection mortality and morbidity. However, epidemiologists 
must stay alert for any new mutation to develop in influenza 
A virus family as it affects around half of the childhood with 
ILI cases. This will allow the timely detection of an epidemic 
or pandemic, detect changes in behavior of circulating 
influenza A virus family, inform decisions on health policy 
and clinical management, and guide the selection of strains 
for vaccines in Egypt.
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